Adherence to lipid-lowering guidelines for secondary prevention and potential reduction in CVD events in Swedish primary care: a cross-sectional study.
Helena ÖdesjöStaffan BjörckStefan FranzénPer HjerpeKarin ManhemAnnika RosengrenJörgen ThornSamuel Adamsson ErydPublished in: BMJ open (2020)
One-third of patients with CHD in primary care were not on lipid-lowering treatment. Based on the assumption that included patients would react to statin therapy the same way as the patients in randomised trials, improved adherence to treatment guidelines could lead to a substantial reduction in new CVD events.
Keyphrases
- primary care
- end stage renal disease
- newly diagnosed
- ejection fraction
- clinical trial
- peritoneal dialysis
- cardiovascular disease
- randomized controlled trial
- type diabetes
- physical activity
- adipose tissue
- risk factors
- fatty acid
- metabolic syndrome
- replacement therapy
- weight loss
- insulin resistance
- smoking cessation
- cell therapy